Literature DB >> 18156931

Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.

Hiroshi Nakano1, Elie Oussoultzoglou, Edoardo Rosso, Selenia Casnedi, Marie-Pierre Chenard-Neu, Patrick Dufour, Philippe Bachellier, Daniel Jaeck.   

Abstract

OBJECTIVE: To investigate whether sinusoidal injury (SI) was associated with a worse outcome after hepatectomy in patients with colorectal liver metastases (CRLM).
BACKGROUND: Correlation between SI and oxaliplatin-based chemotherapy (OBC) was recently shown in patients with CRLM. However, it has yet to be fully clarified whether SI affects liver functional reserve and outcome after hepatectomy. PATIENTS AND METHODS: Between 2003 and 2005, 90 patients with CRLM who underwent an elective hepatectomy after preoperative chemotherapies were included. Diagnosis of SI was established pathologically in the nontumoral liver parenchyma of the resected specimens, and perioperative data were assessed in these patients.
RESULTS: OBC was significantly associated with a higher incidence of SI. Preoperative indocyanine green retention rate at 15 minutes (ICG-R15) and postoperative value of total-bilirubin were significantly higher, and hospital stay was significantly longer in patients presenting with SI. Multivariate analysis showed that female gender, administration of 6 cycles or more of OBC, abnormal value of preoperative aspartate aminotransferase >36 IU/L, or abnormal value of preoperative ICG-R15 (>10%) were preoperative factors significantly associated with SI. Among patients undergoing a major hepatectomy, SI was significantly associated with higher morbidity and longer hospital stay.
CONCLUSION: The present study suggests that SI resulted in a poorer liver functional reserve and in a higher complication rate after major hepatectomy. Therefore, female patients who received 6 cycles or more of OBC, or presenting with abnormal preoperative aspartate aminotransferase and ICG-R15 values should be carefully selected before deciding to undertake a major hepatectomy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18156931     DOI: 10.1097/SLA.0b013e31815774de

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  135 in total

1.  Recent advances in the curative treatment of colorectal liver metastases.

Authors:  Andreas Andreou; Thomas A Aloia; Antoine Brouquet; Jean-Nicolas Vauthey
Journal:  Gastrointest Cancer Res       Date:  2011-07

Review 2.  Curable metastatic colorectal cancer: recommended paradigms.

Authors:  Richard N Berri; Eddie K Abdalla
Journal:  Curr Oncol Rep       Date:  2009-05       Impact factor: 5.075

Review 3.  Liver function impairment in liver transplantation and after extended hepatectomy.

Authors:  Matteo Serenari; Matteo Cescon; Alessandro Cucchetti; Antonio Daniele Pinna
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

4.  Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases.

Authors:  Raja R Narayan; Jennifer W Harris; Joanne F Chou; Mithat Gönen; Fei Bao; Jinru Shia; Peter J Allen; Vinod P Balachandran; Jeffrey A Drebin; William R Jarnagin; Nancy E Kemeny; T Peter Kingham; Michael I D'Angelica
Journal:  Ann Surg Oncol       Date:  2019-10-15       Impact factor: 5.344

5.  Noninvasive assessment of hepatic sinusoidal obstructive syndrome using acoustic radiation force impulse elastography imaging: A proof-of-concept study in rat models.

Authors:  So Hyun Park; Seung Soo Lee; Ji-Youn Sung; Kiyong Na; Hyoung Jung Kim; So Yeon Kim; Beom Jin Park; Jae Ho Byun
Journal:  Eur Radiol       Date:  2017-12-07       Impact factor: 5.315

6.  Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers.

Authors:  Satoshi Nagayama; Suguru Hasegawa; Koya Hida; Kenji Kawada; Etsuro Hatano; Kojiro Nakamura; Satoru Seo; Kojiro Taura; Kentaro Yasuchika; Takashi Matsuo; Masazumi Zaima; Akiyoshi Kanazawa; Hiroaki Terajima; Masaharu Tada; Yukihito Adachi; Ryuta Nishitai; Dai Manaka; Tsunehiro Yoshimura; Koji Doi; Takahiro Horimatsu; Akira Mitsuyoshi; Kenichi Yoshimura; Miyuki Niimi; Shigemi Matsumoto; Yoshiharu Sakai; Shinji Uemoto
Journal:  Int J Clin Oncol       Date:  2016-10-17       Impact factor: 3.402

7.  N-acetylcysteine administration does not improve patient outcome after liver resection.

Authors:  Stuart M Robinson; Rehan Saif; Gourab Sen; Jeremy J French; Bryon C Jaques; Richard M Charnley; Derek M Manas; Steven A White
Journal:  HPB (Oxford)       Date:  2013-01-07       Impact factor: 3.647

8.  Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: factors predictive of severe SOS lesions and protective effect of bevacizumab.

Authors:  Catherine Hubert; Christine Sempoux; Yves Humblet; Marc van den Eynde; Francis Zech; Isabelle Leclercq; Jean-François Gigot
Journal:  HPB (Oxford)       Date:  2013-01-18       Impact factor: 3.647

9.  Limiting factors for liver regeneration after a major hepatic resection for colorectal cancer metastases.

Authors:  Christian Sturesson; Jan Nilsson; Sam Eriksson; Lidewij Spelt; Roland Andersson
Journal:  HPB (Oxford)       Date:  2013-01-10       Impact factor: 3.647

10.  Magnetic resonance imaging flowmetry demonstrates portal vein dilatation subsequent to oxaliplatin therapy in patients with colorectal liver metastasis.

Authors:  Jozef Urdzik; Tomas Bjerner; Alkwin Wanders; Frans Duraj; Ulf Haglund; Agneta Norén
Journal:  HPB (Oxford)       Date:  2012-08-20       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.